CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-12-01 | Cormack Scott Daniel President and CEO | Option exercise · Stock Options | −1,291 | 20,268 | ||
| 2010-11-16 | Cormack Scott Daniel President and CEO | Option exercise | +5,000 | $3.89 | $19K | 18,067 |
| 2010-11-16 | Cormack Scott Daniel President and CEO | Gift | −5,000 | 13,067 | ||
| 2010-11-16 | Cormack Scott Daniel President and CEO | Gift | +5,000 | 30,680 | ||
| 2010-11-16 | Cormack Scott Daniel President and CEO | Option exercise · Stock Option | −5,000 | 3,709 | ||
| 2010-11-15 | Cormack Scott Daniel President and CEO | Option exercise | +5,000 | $3.89 | $19K | 13,092 |
| 2010-11-15 | Cormack Scott Daniel President and CEO | Sale | −5,000 | $15.99 | $80K | 8,092 |
| 2010-11-15 | Cormack Scott Daniel President and CEO | Option exercise · stock option | −5,000 | 1,533 | ||
| 2010-11-09 | Lawrence Cameron William Principal Financial Officer | Purchase | +650 | $15.73 | $10K | 3,050 |
| 2010-11-01 | Cormack Scott Daniel President and CEO | Option exercise | +10,000 | $3.89 | $39K | 18,067 |
| 2010-11-01 | Cormack Scott Daniel President and CEO | Sale | −5,000 | $15.45 | $77K | 13,067 |
| 2010-11-01 | Cormack Scott Daniel President and CEO | Option exercise · Employee Stock Option (right to buy) | −10,000 | 8,709 | ||
| 2010-08-25 | Cormack Scott Daniel President & CEO | Option exercise | +1,761 | $3.89 | $7K | 8,067 |
| 2010-08-25 | Cormack Scott Daniel President & CEO | Option exercise · Employee Stock Option (right to buy) | −1,761 | 18,709 | ||
| 2010-08-09 | Smith David V Director | Grant or award · Employee Stock Option (Right to Buy) | +5,500 | 5,500 |
Page 36 of 36 · 715 trades